Demographic changes are one of the key growth factors driving the market for peripheral vascular interventions and diagnostics for peripheral artery disease (PAD). Other factors include new technological developments, such as drug-eluting balloons, which are improving clinical success rates and expanding the number of patients who can be treated.
The initial approach to assessing a patient with suspected PAD is to measure the ankle brachial pressure index (ABI), which...